#gpat2024 #pharmatipszone #trastuzumab#trending #competetive exam
Description
Question: Trastuzumab is a/an
A. EGFR/HER 2 inhibitor
B. Angiogenesis inhibitor
C. EGF Receptor HER inhibitor
D. BCR-ABL tyrosine kinase inhibitors
Answer: EGFR/HER 2 inhibitor.
Solution: Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.
